Swayampakula Ramakanth
Stock Analyst at HC Wainwright & Co.
(1.94)
# 2,877
Out of 4,784 analysts
455
Total ratings
32.17%
Success rate
-8.34%
Average return
Main Sectors:
Stocks Rated by Swayampakula Ramakanth
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IPHA Innate Pharma | Reiterates: Buy | $12 | $1.98 | +480.81% | 15 | Mar 28, 2025 | |
| EDAP EDAP TMS | Reiterates: Buy | $19 | $2.15 | +783.72% | 14 | Mar 28, 2025 | |
| RNXT RenovoRx | Initiates: Buy | $3 | $1.00 | +200.00% | 1 | Mar 27, 2025 | |
| LPTX Leap Therapeutics | Reiterates: Neutral | n/a | $0.32 | - | 15 | Mar 27, 2025 | |
| XFOR X4 Pharmaceuticals | Reiterates: Buy | $1.5 | $0.25 | +500.00% | 15 | Mar 27, 2025 | |
| VOR Vor Biopharma | Maintains: Buy | $18 → $13 | $0.75 | +1,626.66% | 11 | Mar 21, 2025 | |
| ELEV Elevation Oncology | Maintains: Buy | $6 → $1 | $0.26 | +284.62% | 9 | Mar 21, 2025 | |
| MDWD MediWound | Reiterates: Buy | $25 | $15.95 | +56.74% | 18 | Mar 20, 2025 | |
| PGEN Precigen | Reiterates: Buy | $6 | $1.59 | +277.36% | 10 | Mar 20, 2025 | |
| ABSI Absci | Reiterates: Buy | $7 | $2.70 | +159.26% | 14 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $1.06 | +371.70% | 8 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $33 | $13.02 | +153.46% | 7 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3.5 | $1.13 | +209.73% | 3 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $7.90 | +153.16% | 1 | Mar 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $6 | $0.20 | +2,959.66% | 15 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $0.39 | +1,685.71% | 9 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $6.45 | +287.60% | 13 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $19.99 | +100.10% | 5 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $13 | $1.79 | +626.26% | 7 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $24 | $13.15 | +82.51% | 12 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $0.66 | +663.24% | 14 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $0.80 | +900.63% | 20 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $46 | $6.32 | +627.85% | 11 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $0.44 | +1,959.50% | 14 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $70 | $29.10 | +140.55% | 12 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $110 | $73.05 | +50.58% | 3 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $3.62 | +120.99% | 14 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 | $44.50 | +34.83% | 18 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $115 | $54.63 | +110.51% | 20 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $33 | $8.97 | +267.89% | 18 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $14 | $1.76 | +695.45% | 11 | Feb 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5.5 | $1.27 | +333.07% | 6 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $0.78 | +1,180.25% | 12 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $2.55 | +331.37% | 11 | Nov 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $1.95 | +156.41% | 2 | Nov 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $27 | $10.24 | +163.67% | 5 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.45 | - | 2 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $7.54 | +45.89% | 8 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $1.99 | +905.03% | 1 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $4.32 | +108.33% | 1 | Dec 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.46 | - | 2 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.81 | - | 12 | May 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $1.29 | +597.67% | 1 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $25 | $1.77 | +1,310.04% | 2 | Jan 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $1.56 | +221.54% | 1 | Dec 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $4 | $0.33 | +1,094.74% | 1 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $12 | $2.15 | +458.82% | 2 | Aug 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $20 | $0.37 | +5,257.62% | 2 | Aug 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $16.60 | - | 8 | May 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $80 | $1.18 | +6,679.66% | 5 | Feb 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9.5 → $6 | $3.38 | +77.51% | 4 | Jul 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $15 | $7.52 | +99.47% | 5 | Nov 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $33 | $6.19 | +433.12% | 1 | Mar 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 → $9.5 | $10.19 | -6.77% | 3 | Mar 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18,000 → $14,000 | $2.79 | +501,692.11% | 1 | Mar 5, 2020 |
Innate Pharma
Mar 28, 2025
Reiterates: Buy
Price Target: $12
Current: $1.98
Upside: +480.81%
EDAP TMS
Mar 28, 2025
Reiterates: Buy
Price Target: $19
Current: $2.15
Upside: +783.72%
RenovoRx
Mar 27, 2025
Initiates: Buy
Price Target: $3
Current: $1.00
Upside: +200.00%
Leap Therapeutics
Mar 27, 2025
Reiterates: Neutral
Price Target: n/a
Current: $0.32
Upside: -
X4 Pharmaceuticals
Mar 27, 2025
Reiterates: Buy
Price Target: $1.5
Current: $0.25
Upside: +500.00%
Vor Biopharma
Mar 21, 2025
Maintains: Buy
Price Target: $18 → $13
Current: $0.75
Upside: +1,626.66%
Elevation Oncology
Mar 21, 2025
Maintains: Buy
Price Target: $6 → $1
Current: $0.26
Upside: +284.62%
MediWound
Mar 20, 2025
Reiterates: Buy
Price Target: $25
Current: $15.95
Upside: +56.74%
Precigen
Mar 20, 2025
Reiterates: Buy
Price Target: $6
Current: $1.59
Upside: +277.36%
Absci
Mar 19, 2025
Reiterates: Buy
Price Target: $7
Current: $2.70
Upside: +159.26%
Mar 19, 2025
Reiterates: Buy
Price Target: $5
Current: $1.06
Upside: +371.70%
Mar 19, 2025
Reiterates: Buy
Price Target: $33
Current: $13.02
Upside: +153.46%
Mar 18, 2025
Reiterates: Buy
Price Target: $3.5
Current: $1.13
Upside: +209.73%
Mar 17, 2025
Initiates: Buy
Price Target: $20
Current: $7.90
Upside: +153.16%
Mar 14, 2025
Maintains: Buy
Price Target: $8 → $6
Current: $0.20
Upside: +2,959.66%
Mar 14, 2025
Reiterates: Buy
Price Target: $7
Current: $0.39
Upside: +1,685.71%
Mar 13, 2025
Reiterates: Buy
Price Target: $25
Current: $6.45
Upside: +287.60%
Mar 12, 2025
Reiterates: Buy
Price Target: $40
Current: $19.99
Upside: +100.10%
Mar 11, 2025
Reiterates: Buy
Price Target: $13
Current: $1.79
Upside: +626.26%
Mar 7, 2025
Maintains: Buy
Price Target: $22 → $24
Current: $13.15
Upside: +82.51%
Mar 7, 2025
Reiterates: Buy
Price Target: $5
Current: $0.66
Upside: +663.24%
Mar 6, 2025
Reiterates: Buy
Price Target: $8
Current: $0.80
Upside: +900.63%
Mar 6, 2025
Reiterates: Buy
Price Target: $46
Current: $6.32
Upside: +627.85%
Mar 4, 2025
Reiterates: Buy
Price Target: $9
Current: $0.44
Upside: +1,959.50%
Mar 3, 2025
Reiterates: Buy
Price Target: $70
Current: $29.10
Upside: +140.55%
Mar 3, 2025
Reiterates: Buy
Price Target: $110
Current: $73.05
Upside: +50.58%
Feb 28, 2025
Reiterates: Buy
Price Target: $8
Current: $3.62
Upside: +120.99%
Feb 28, 2025
Reiterates: Buy
Price Target: $60
Current: $44.50
Upside: +34.83%
Feb 27, 2025
Reiterates: Buy
Price Target: $115
Current: $54.63
Upside: +110.51%
Feb 26, 2025
Reiterates: Buy
Price Target: $33
Current: $8.97
Upside: +267.89%
Feb 20, 2025
Reiterates: Buy
Price Target: $14
Current: $1.76
Upside: +695.45%
Jan 14, 2025
Reiterates: Buy
Price Target: $5.5
Current: $1.27
Upside: +333.07%
Dec 10, 2024
Reiterates: Buy
Price Target: $10
Current: $0.78
Upside: +1,180.25%
Nov 29, 2024
Reiterates: Buy
Price Target: $11
Current: $2.55
Upside: +331.37%
Nov 21, 2024
Reiterates: Buy
Price Target: $5
Current: $1.95
Upside: +156.41%
Nov 15, 2024
Reiterates: Buy
Price Target: $27
Current: $10.24
Upside: +163.67%
Nov 15, 2024
Downgrades: Neutral
Price Target: n/a
Current: $1.45
Upside: -
May 1, 2024
Reiterates: Buy
Price Target: $11
Current: $7.54
Upside: +45.89%
Apr 1, 2024
Reiterates: Buy
Price Target: $20
Current: $1.99
Upside: +905.03%
Dec 8, 2023
Initiates: Buy
Price Target: $9
Current: $4.32
Upside: +108.33%
Aug 16, 2023
Downgrades: Neutral
Price Target: n/a
Current: $1.46
Upside: -
May 9, 2023
Downgrades: Neutral
Price Target: n/a
Current: $2.81
Upside: -
Feb 17, 2023
Reiterates: Buy
Price Target: $9
Current: $1.29
Upside: +597.67%
Jan 30, 2023
Maintains: Buy
Price Target: $150 → $25
Current: $1.77
Upside: +1,310.04%
Dec 7, 2022
Initiates: Buy
Price Target: $5
Current: $1.56
Upside: +221.54%
Nov 4, 2022
Maintains: Buy
Price Target: $3 → $4
Current: $0.33
Upside: +1,094.74%
Aug 15, 2022
Maintains: Buy
Price Target: $3 → $12
Current: $2.15
Upside: +458.82%
Aug 10, 2022
Maintains: Buy
Price Target: $25 → $20
Current: $0.37
Upside: +5,257.62%
May 13, 2022
Downgrades: Neutral
Price Target: n/a
Current: $16.60
Upside: -
Feb 17, 2022
Maintains: Buy
Price Target: $150 → $80
Current: $1.18
Upside: +6,679.66%
Jul 16, 2021
Maintains: Buy
Price Target: $9.5 → $6
Current: $3.38
Upside: +77.51%
Nov 9, 2020
Maintains: Buy
Price Target: $20 → $15
Current: $7.52
Upside: +99.47%
Mar 16, 2020
Maintains: Buy
Price Target: $30 → $33
Current: $6.19
Upside: +433.12%
Mar 6, 2020
Reiterates: Buy
Price Target: $8 → $9.5
Current: $10.19
Upside: -6.77%
Mar 5, 2020
Reiterates: Buy
Price Target: $18,000 → $14,000
Current: $2.79
Upside: +501,692.11%